A | OUR PEOPLE HAVE SHOWN TREMENDOUS RESILIENCY AND CREATIVITY in continuing to advance our mission of developing medicines that provide a profound benefit for patients. They have done that, first and foremost, by supporting each other, and, in doing so, we have stayed strong as a team. That strength has allowed us to adapt to dramatically altered circumstances, completing enrollment in one clinical trial, initiating enrollment in a new cohort in another trial, and remaining on track for multiple clinical data readouts this year and next. Looking ahead, I believe that if we keep our focus on teamwork, supporting each other through whatever challenges lie ahead, we will emerge a stronger, more nimble and flexible organization.
JOSEPH FERRA is CFO of Syros Pharmaceuticals. Previously, he served in multiple senior roles in the investment banking sector.